tuberostemonine has been researched along with Alveolitis, Fibrosing in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, S; Hu, Y; Lv, X; Song, X; Tang, X; Zhang, M; Zhu, Q | 1 |
| Cao, F; Liu, M; Liu, Y; Tang, A; Xu, C; Yang, C | 1 |
2 other study(ies) available for tuberostemonine and Alveolitis, Fibrosing
| Article | Year |
|---|---|
Neotuberostemonine and tuberostemonine ameliorate pulmonary fibrosis through suppressing TGF-β and SDF-1 secreted by macrophages and fibroblasts via the PI3K-dependent AKT and ERK pathways.
Topics: Alkaloids; Animals; Fibroblasts; Macrophages; MAP Kinase Signaling System; Mice; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Pulmonary Fibrosis; Transforming Growth Factor beta | 2023 |
Tuberostemonine may enhance the function of the SLC7A11/glutamate antiporter to restrain the ferroptosis to alleviate pulmonary fibrosis.
Topics: Amino Acid Transport System y+; Animals; Bleomycin; Collagen; Ferroptosis; Glutamic Acid; Humans; Hydroxyproline; Ions; Mice; Pulmonary Fibrosis; Transforming Growth Factor beta1 | 2024 |